Improving the Reliability of Pharmacokinetic Parameters at Dynamic Contrast-enhanced MRI in Astrocytomas: A Deep Learning Approach.

Journal: Radiology
Published Date:

Abstract

Background Pharmacokinetic (PK) parameters obtained from dynamic contrast agent-enhanced (DCE) MRI evaluates the microcirculation permeability of astrocytomas, but the unreliability from arterial input function (AIF) remains a challenge. Purpose To develop a deep learning model that improves the reliability of AIF for DCE MRI and to validate the reliability and diagnostic performance of PK parameters by using improved AIF in grading astrocytomas. Materials and Methods This retrospective study included 386 patients (mean age, 52 years ± 16 [standard deviation]; 226 men) with astrocytomas diagnosed with histopathologic analysis who underwent dynamic susceptibility contrast (DSC)-enhanced and DCE MRI preoperatively from April 2010 to January 2018. The AIF was obtained from each sequence: AIF obtained from DSC-enhanced MRI (AIF) and AIF measured at DCE MRI (AIF). The model was trained to translate AIF into AIF, and after training, outputted neural-network-generated AIF (AIF) with input AIF. By using the three different AIFs, volume transfer constant (), fractional volume of extravascular extracellular space (V), and vascular plasma space (V) were averaged from the tumor areas in the DCE MRI. To validate the model, intraclass correlation coefficients and areas under the receiver operating characteristic curve (AUCs) of the PK parameters in grading astrocytomas were compared by using different AIFs. Results The AIF-generated, DSC-derived PK parameters showed higher AUCs in grading astrocytomas than those derived from AIF (mean , 0.88 [95% confidence interval {CI}: 0.81, 0.93] vs 0.72 [95% CI: 0.63, 0.79], = .04; mean V, 0.87 [95% CI: 0.79, 0.92] vs 0.70 [95% CI: 0.61, 0.77], = .049, respectively). and V showed higher intraclass correlation coefficients for AIF than for AIF (0.91 vs 0.38, < .001; and 0.86 vs 0.60, < .001, respectively). In AIF analysis, baseline signal intensity (SI), maximal SI, and wash-in slope showed higher intraclass correlation coefficients with AIF than AIF (0.77 vs 0.29, < .001; 0.68 vs 0.42, = .003; and 0.66 vs 0.45, = .01, respectively. Conclusion A deep learning algorithm improved both reliability and diagnostic performance of MRI pharmacokinetic parameters for differentiating astrocytoma grades. © RSNA, 2020

Authors

  • Kyu Sung Choi
    Graduate School of Medical Science and Engineering, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Sung-Hye You
    From the Graduate School of Medical Science and Engineering, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea (K.S.C., B.J.); Department of Radiology, Korea University College of Medicine, Anam Hospital, Seoul, Republic of Korea (S.H.Y.); Bio Imaging and Signal Processing Laboratory, Department of Bio and Brain Engineering, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea (Y.H., J.C.Y.); Department of Radiology, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 110-744, Republic of Korea (S.H.C.); Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea (S.H.C.); Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Republic of Korea (S.H.C.); KAIST Institute for Health Science and Technology, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea (B.J.); and KAIST Institute for Artificial Intelligence, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea (B.J.).
  • Yoseob Han
    Department of Bio and Brain Engineering, Korea Advanced Institute of Science & Technology (KAIST), Daejeon, Republic of Korea.
  • Jong Chul Ye
  • Bumseok Jeong
    Graduate School of Medical Science and Engineering, Korea Advanced Institute for Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Seung Hong Choi
    From the Graduate School of Medical Science and Engineering (K.H.K., S.H.P.) and Department of Bio and Brain Engineering (S.H.P.), Korea Advanced Institute of Science and Technology, Room 1002, CMS (E16) Building, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea (S.H.C.); Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea (S.H.C.); and Center for Nanoparticle Research, Institute for Basic Science, Seoul, Republic of Korea (S.H.C.).